STOCKHOLM, July 16, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the drug discovery research for lecanemab (product name Leqembi®), an antibody indicated for early Alzheimer's disease which was co-developed by Eisai and...
Hence then, the article about the drug discovery research for lecanemab awarded the 9th bioindustry award by the japan bioindustry association was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( The drug discovery research for lecanemab awarded the 9th Bioindustry Award by the Japan Bioindustry Association )
Also on site :
- Police called to multiple central Ohio schools after alleged bomb threats
- Doctors Are Seeing a Bizarre New COVID Symptom Right Now
- 3 questions every CEO needs to ask about the AI jobs doom loop in the wake of Jack Dorsey’s dramatic 40% layoffs at Block